Clinical Trial Update: Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer [Phase 2]

View source ↗

Summary

Takeda-sponsored phase 2 trial evaluating niraparib as maintenance therapy in Japanese participants with relapsed ovarian cancer has completed and posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: Takeda | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-03-25